T cell-mediated heterologous immunity to different pathogens is promising for the development of immunotherapeutic strategies. Aspergillus fumigatus and Candida albicans, the 2 most common fungal pathogens causing severe infections in immunocompromised patients, are controlled by CD4+ type 1 helper T (TH1) cells in humans and mice, making induction of fungus-specific CD4+ TH1 immunity an appealing strategy for antifungal therapy. We identified an immunogenic epitope of the A fumigatus cell wall glucanase Crf1 that can be presented by 3 common major histocompatibility complex class II alleles and that induces memory CD4+ TH1 cells with a diverse T-cell receptor repertoire that is cross-reactive to C albicans. In BALB/c mice, the Crf1 protein also elicits cross-protection against lethal infection with C albicans that is mediated by the same epitope as in humans. These data illustrate the existence of T cell-based cross-protection for the 2 distantly related clinically relevant fungal pathogens that may foster the development of immunotherapeutic strategies. © 2011 by The American Society of Hematology.
CITATION STYLE
Stuehler, C., Khanna, N., Bozza, S., Zelante, T., Moretti, S., Kruhm, M., … Topp, M. S. (2011). Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans. Blood, 117(22), 5881–5891. https://doi.org/10.1182/blood-2010-12-325084
Mendeley helps you to discover research relevant for your work.